Novo Nordisk: The New PayPal? [Seeking Alpha]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Seeking Alpha
Despite margin compression and weak 2026 guidance, NVO remains a cash-generative leader in the expanding obesity market. Even under bearish scenarios, downside risk appears limited, with robust free cash flow and high gross margins supporting valuation. NVO's current valuation offers an attractive entry point for long-term investors anticipating eventual sentiment recovery. This idea was discussed in more depth with members of my private investing community, The Pragmatic Investor. Learn More » Henrik Sorensen/DigitalVision via Getty Images Thesis Summary Just when you think Novo Nordisk A/S ( NVO can't go any lower, it gets some more bad news, and the stock dips further. The stock already collapsed in 2025 as GLP-1 enthusiasm faded and political pressure intensified. Now, just More on my IG service Macro moves markets, and this is what I do at The Pragmatic Investor Join today and enjoy: - Weekly Macro Newsletter - Access to our Portfolio - Deep dive repo
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026 [Yahoo! Finance]Yahoo! Finance
- Healthy Returns: What's next for Novo Nordisk's next-generation obesity drug CagriSema after trial miss [CNBC]CNBC
- Novo Nordisk to slash list prices of Ozempic, Wegovy by up to 50% [FOX Business Network]FOX Business Network
- Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 [CNN]CNN
- Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 [CNN]CNN
NVO
Earnings
- 2/3/26 - Beat
NVO
Sec Filings
- 2/23/26 - Form 6-K
- 2/23/26 - Form 6-K
- 2/20/26 - Form 6-K
- NVO's page on the SEC website